Fig. 8: Graphical summary of the proposed mechanism.

A schematic diagram illustrates the working model in which SPOP mutants enhance ELK3 stabilization, leading to increased resistance to docetaxel-induced cell death. Consequently, the SPOP-ELK3 axis plays a pivotal role in the progression of prostate cancer (PCa).